ConductScience.org, home

Paper4154071

[Immunosuppression and induction of tolerance by 3-(2-chloroethyl)-2(2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (ASTA 5122)].

Botzenhardt U and 1 other. Arzneimittelforschung, 1974. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. [Immunosuppression and induction of tolerance by 3-(2-chloroethyl)-2(2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (ASTA 5122)]. Papers, record 4154071. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4154071

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Immunosuppression and induction of tolerance by 3-(2-chloroethyl)-2(2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide (ASTA 5122)].
PubMed
Journal
Arzneimittelforschung
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.38
iCite
Revised in PubMed
2021-12-03
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Botzenhardt UU
2Lemmel EME M

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Cyclic P-OxidesMajor topic
Immune ToleranceMajor topic
Immunosuppression TherapyMajor topic
Immunosuppressive AgentsMajor topic
OxazinesMajor topic
Animals
Antibody Formation
Depression, Chemical
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Graft vs Host Reaction
Hemagglutination
Hemolytic Plaque Technique
Injections, Intraperitoneal
Lethal Dose 50
Leukocyte Count
Leukopenia
Lymphocytes
Mesylates
Mice
Spleen

Source PubMed

Download CSV of topics

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
970288Comparison of the immunosuppressive efficacy of 6-mercaptopurine, azathioprine, cyclophosphamide and 036.5122 (Asta) on the primary and secondary immune response of mice to sheep erythrocytes.Agents Actions1976https://conductscience.org/library/papers/970288PubMed
769507
Kinetics of the reactive cell clones after immunosuppression and induction of tolerance: (1) inhibition of 19 S and 7 S plaque-forming cells in the primary and secondary immune response to sheep red blood cells by cyclophosphamide and 036.5122 (Asta).
Agents Actions1975https://conductscience.org/library/papers/769507PubMed
198323Virus induced diabetes and the immune system. I. Suggestion that appearance of diabetes depends on immune reactions.Diabetologia1977https://conductscience.org/library/papers/198323PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4154071

GET https://conductscience.org/api/papers/v1/4154071/authors